Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Sales | 5,994,000 | 7,824,000 | 7,622,000 | 7,584,000 | 8,105,000 |
| Cost of Goods | 272,000 | 1,177,000 | 1,150,000 | 1,224,000 | 2,068,000 |
| Gross Profit | 5,722,000 | 6,647,000 | 6,472,000 | 6,360,000 | 8,945,000 |
| Operating Expenses | 3,529,000 | 3,898,000 | 4,068,000 | 3,817,000 | 5,818,000 |
| Operating Income | 2,193,000 | 2,749,000 | 2,404,000 | 2,543,000 | 219,000 |
| Other Income | 46,000 | 5,000 | -13,000 | 57,000 | 497,000 |
| Pre-tax Income | 2,239,000 | 2,754,000 | 2,391,000 | 2,600,000 | 716,000 |
| Income Tax | 496,000 | 679,000 | 590,000 | 668,000 | 683,000 |
| Net Income Continuous | 1,743,000 | 2,072,000 | 1,792,000 | 1,930,000 | 1,412,000 |
| Net Income Discontinuous | 214,000 | N/A | 37,000 | N/A | 8,000 |
| Net Income | $1,957,000 | $2,072,000 | $1,829,000 | $1,930,000 | $1,420,000 |
| EPS Basic Total Ops | 0.32 | 0.33 | 0.29 | 0.31 | 0.23 |
| EPS Basic Continuous Ops | 0.28 | 0.33 | 0.29 | 0.31 | 0.23 |
| EPS Basic Discontinuous Ops | 0.03 | N/A | 0.01 | N/A | 0.00 |
| EPS Diluted Total Ops | 0.30 | 0.33 | 0.29 | 0.30 | 0.23 |
| EPS Diluted Continuous Ops | 0.26 | 0.33 | 0.29 | 0.30 | 0.23 |
| EPS Diluted Discontinuous Ops | 0.03 | N/A | 0.01 | N/A | 0.00 |
| EBITDA(a) | $2,393,000 | $2,999,000 | $2,672,000 | $2,797,000 | $480,000 |